- Home
- SNEX vs PCVX Comparison
SNEX vs PCVX Comparison
Compare SNEX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNEX
- PCVX
- Stock Information
- Founded
- SNEX 1924
- PCVX 2013
- Country
- SNEX United States
- PCVX United States
- Employees
- SNEX N/A
- PCVX N/A
- Industry
- SNEX Investment Bankers/Brokers/Service
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- SNEX Finance
- PCVX Health Care
- Exchange
- SNEX Nasdaq
- PCVX Nasdaq
- Market Cap
- SNEX 4.3B
- PCVX 4.5B
- IPO Year
- SNEX 1994
- PCVX 2020
- Fundamental
- Price
- SNEX $88.63
- PCVX $31.16
- Analyst Decision
- SNEX Buy
- PCVX Strong Buy
- Analyst Count
- SNEX 1
- PCVX 10
- Target Price
- SNEX N/A
- PCVX $136.50
- AVG Volume (30 Days)
- SNEX 441.0K
- PCVX 2.2M
- Earning Date
- SNEX 05-07-2025
- PCVX 05-07-2025
- Dividend Yield
- SNEX N/A
- PCVX N/A
- EPS Growth
- SNEX 17.99
- PCVX N/A
- EPS
- SNEX 5.90
- PCVX N/A
- Revenue
- SNEX $121,723,000,000.00
- PCVX N/A
- Revenue This Year
- SNEX N/A
- PCVX N/A
- Revenue Next Year
- SNEX $3.36
- PCVX N/A
- P/E Ratio
- SNEX $14.99
- PCVX N/A
- Revenue Growth
- SNEX 68.26
- PCVX N/A
- 52 Week Low
- SNEX $46.43
- PCVX $27.66
- 52 Week High
- SNEX $97.17
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- SNEX 57.48
- PCVX 36.73
- Support Level
- SNEX $90.00
- PCVX $28.09
- Resistance Level
- SNEX $97.17
- PCVX $33.75
- Average True Range (ATR)
- SNEX 3.58
- PCVX 2.54
- MACD
- SNEX 0.13
- PCVX 1.12
- Stochastic Oscillator
- SNEX 53.64
- PCVX 35.61
About SNEX StoneX Group Inc.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.